BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30314310)

  • 1. Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature.
    Pannunzio A; Coluccia M
    Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30314310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between cyclooxygenase-2 protein expression, prostaglandins levels and biologic behavior in ovarian carcinoma tissue].
    Tang L; Wang M; Ma J
    Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):687-90. PubMed ID: 12487927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
    Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
    J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenases in the skin: pharmacological and toxicological implications.
    Lee JL; Mukhtar H; Bickers DR; Kopelovich L; Athar M
    Toxicol Appl Pharmacol; 2003 Nov; 192(3):294-306. PubMed ID: 14575647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arachidonic acid and prostaglandins, inflammation and oncology].
    Eschwège P; de Ledinghen V; Camilli T; Kulkarni S; Dalbagni G; Droupy S; Jardin A; Benoît G; Weksler BB
    Presse Med; 2001 Mar; 30(10):508-10. PubMed ID: 11307496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds.
    Baber SR; Champion HC; Bivalacqua TJ; Hyman AL; Kadowitz PJ
    Circulation; 2003 Aug; 108(7):896-901. PubMed ID: 12900348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 biology.
    Clària J
    Curr Pharm Des; 2003; 9(27):2177-90. PubMed ID: 14529398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence.
    Müller-Decker K
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):343-61. PubMed ID: 22038018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2: a novel target for cancer chemotherapy?
    Dempke W; Rie C; Grothey A; Schmoll HJ
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.
    Gately S; Kerbel R
    Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Ford-Hutchinson AW; Forrest MJ; Gauthier JY; Gordon R; Gresser M; Guay J; Kargman S; Kennedy B; Leblanc Y; Leger S; Mancini J; O'Neill GP; Ouellet M; Patrick D; Percival MD; Perrier H; Prasit P; Rodger I
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells.
    Chang HC; Weng CF
    Oncol Rep; 2001; 8(6):1321-5. PubMed ID: 11605058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
    Sheng H; Shao J; Kirkland SC; Isakson P; Coffey RJ; Morrow J; Beauchamp RD; DuBois RN
    J Clin Invest; 1997 May; 99(9):2254-9. PubMed ID: 9151799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression.
    Higashi Y; Kanekura T; Kanzaki T
    Int J Cancer; 2000 Jun; 86(5):667-71. PubMed ID: 10797288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclooxygenase-2, but not cyclooxygenase-1, on type II collagen-induced arthritis in DBA/1J mice.
    Ochi T; Ohkubo Y; Mutoh S
    Biochem Pharmacol; 2003 Sep; 66(6):1055-60. PubMed ID: 12963493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is cyclooxygenase-2 important in skin carcinogenesis?
    Fischer SM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):183-91. PubMed ID: 12086405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The function of the selective inhibitors of cyclooxygenase 2.
    Luan Y; Xu W
    Mini Rev Med Chem; 2006 Dec; 6(12):1375-81. PubMed ID: 17168813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.